BACKGROUND: Accurately identifying time-varying differences in the hazard of all-cause mortality after liver transplantation (LT) between recipients with and without hepatocellular carcinoma (HCC) may inform patient selection and organ allocation policies as well as post-LT surveillance protocols. METHODS: A UK population-based study was carried out using 9586 LT recipients. The time-varying association between HCC and post-LT all-cause mortality was estimated using an adjusted flexible parametric model (FPM) and expressed as hazard ratios (HRs). Differences in this association by transplant year were then investigated. Non-cancer-specific mortality was compared between HCC and non-HCC recipients using an adjusted subdistribution hazard mod...
BACKGROUND & AIMS: An increasing number of patients with non-alcoholic steatohepatitis (NASH) requir...
OBJECTIVE: We assessed the impact of comorbidity on mortality in three periods after liver transplan...
Although hepatocellular carcinoma (HCC) has become a recognized indication for liver transplantation...
BACKGROUND: Patients who receive a liver transplant for hepatocellular carcinoma (HCC) often receive...
Background and Aims: Prognosis after liver transplantation differs between hepatocellular carcinoma ...
Prognosis after liver transplantation differs between hepatocellular carcinoma (HCC) arising in cirr...
Hepatocellular carcinoma (HCC) as an indication to liver transplant (LT) started as palliative treat...
We examined mortality and recurrence of hepatocellular carcinoma (HCC) among 106 transplant candidat...
Abstract Controversy exists regarding whether the rate of hepatocellular carcinoma (HCC) recurrence ...
Hepatic resection (HR) for hepatocellular carcinoma (HCC) may require secondary liver transplantatio...
BACKGROUND: Compared with the United States, risk-adjusted mortality in the United Kingdom has histo...
BACKGROUND: Compared with the United States, risk-adjusted mortality in the United Kingdom has histo...
BACKGROUND: Transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC) a...
Recurrence of hepatocellular carcinoma (HCC) is an important predictor of survival after liver trans...
Background & Aims: In the USA, inequal liver transplantation (LT) access exists between patients...
BACKGROUND & AIMS: An increasing number of patients with non-alcoholic steatohepatitis (NASH) requir...
OBJECTIVE: We assessed the impact of comorbidity on mortality in three periods after liver transplan...
Although hepatocellular carcinoma (HCC) has become a recognized indication for liver transplantation...
BACKGROUND: Patients who receive a liver transplant for hepatocellular carcinoma (HCC) often receive...
Background and Aims: Prognosis after liver transplantation differs between hepatocellular carcinoma ...
Prognosis after liver transplantation differs between hepatocellular carcinoma (HCC) arising in cirr...
Hepatocellular carcinoma (HCC) as an indication to liver transplant (LT) started as palliative treat...
We examined mortality and recurrence of hepatocellular carcinoma (HCC) among 106 transplant candidat...
Abstract Controversy exists regarding whether the rate of hepatocellular carcinoma (HCC) recurrence ...
Hepatic resection (HR) for hepatocellular carcinoma (HCC) may require secondary liver transplantatio...
BACKGROUND: Compared with the United States, risk-adjusted mortality in the United Kingdom has histo...
BACKGROUND: Compared with the United States, risk-adjusted mortality in the United Kingdom has histo...
BACKGROUND: Transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC) a...
Recurrence of hepatocellular carcinoma (HCC) is an important predictor of survival after liver trans...
Background & Aims: In the USA, inequal liver transplantation (LT) access exists between patients...
BACKGROUND & AIMS: An increasing number of patients with non-alcoholic steatohepatitis (NASH) requir...
OBJECTIVE: We assessed the impact of comorbidity on mortality in three periods after liver transplan...
Although hepatocellular carcinoma (HCC) has become a recognized indication for liver transplantation...